RB protein expression in human endometrial carcinomas - An immunohistochemical study

Pathology Research and Practice

Volumn 196, Issue 1, 2000, Pages 41-46

  Semczuk, Andrzej ^a   Schneider Stock, Regine ^b   Miturski, Roman ^a   Skomra, Danuta ^a   Tomaszewski, Jacek ^a   Roessner, Albert ^b   Jakowicki, Jerzy A ^a  

^a School of Medicine   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Immunohistochemistry; K ras; Rb

Indexed keywords

AVIDIN; BIOTIN; PEROXIDASE; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE OVEREXPRESSION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION;

EID: 0033968520     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80020-5     Document Type: Article

References (37)

1. Ambros RA, Vigna PA, Figge J, Kallakury BVS, Mastrangelo A, Eastman AY, Malfetano J, Figge HL, Ross JS (1994) Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53. Cancer 73: 1686-1692
2. Bartek J, Bartkova J, Lukas J (1997) The retinoblastoma protein pathway in cell cycle control and cancer. Exp Cell Res 237: 1-6
3. Bookstein R, Rio P, Madreperla SA, Hong F, Allred C, Grizzle WE, Lee WH (1990) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762-7766
4. Borg A, Zhang Q-X, Alm P, Olsson H, Seilberg G (1992) The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991-2994
5. Cairns P, Proctor AJ, Knowles MA (1991) Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6: 2305-2309
6. Enomoto T, Fujita M, Inoue M, Nakazawa-Miyamoto A, Tanizawa O, Nomura T (1993) Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma. Mol Carcinog 8: 132-137
7. FIGO stages, 1988 revision (1989) Gynecol Oncol 35: 125-127
8. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646
9. Hesketh R (1997) The oncogene and tumour suppressor gene, pp 466-175, 2nd edn, Academic Press, San Diego London Boston New York Sydney Toronto
10. Ishikawa J, Xu H-J, Hu S-X, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R (1991) Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51: 5736-5743
11. Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK, Nankoong SE (1997) Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Gynecol Oncol 67: 215-221
12. Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci USA 90: 10914-10921
13. Lee WH, Bookstein R, Hong F, Young L-J, Shew J-Y, Lee EY-HP (1987) Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394-1399
14. Lee EY-WH, To H, Shew J-Y, Bookstein R, Scully P, Lee W-H (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218-221
15. Li S-F, Shiozawa T, Nakayama K, Nikaido T, Fujii S (1996) Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb) and cyclin E in uterine endometrioid carcinoma. Cancer 77: 321-329
16. Michalides RJAM (1999) Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 52: 555-568
17. Milde-Langosch K, Riethdorf L, Bamberger A-M, Loning T (1999) P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch 434: 23-28
18. Miturski R, Semczuk A, Jakowicki J (1996) Simultaneous expression of the ras p21 and p53 proteins in human endometrial carcinomas. Acta Histochem 98: 411-418
19. Miturski R, Semczuk A, Tomaszewski J, Jakowicki J (1998) bcl-2 protein expression in endometrial carcinoma: the lack of correlation with p53. Cancer Lett 133: 63-69
20. Niemann TH, Yilmaz AG, McGaughy VR, Vaccarello L (1997) Retinoblastoma protein expression in endometrial hyperplasia and carcinoma. Gynecol Oncol 65: 232-236
21. Nyholm HCJ, Nielsen AL, Lyndrup J, Norup P, Thorpe SM (1992) Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: Correlation with stage and other clinicopathological features. Am J Obstet Gynecol 167: 1334-1342
22. Parazzini F, La Vecchia C, Bicciolone L, Franceschi S (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41: 1-16
23. Pepper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA, Ewen ME (1997) Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177-181
24. Sasano H, Comerford J, Silverberg SG, Garrett CT (1990) An analysis of abnormalities of the retinoblastoma gene in human ovarian and endometrial carcinoma. Cancer 66: 2150-2154
25. Schneider-Stock R, Walter H, Radig K, Rys J, Bosse A, Kuhnen C, Hoang-Vu C, Roessner A (1998) MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 124: 532-540
26. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EL (1994) Histological typing of female genital tract tumours, pp 14-27, 2nd edn, Springer, Berlin Heidelberg New York
27. Semczuk A, Miturski R, Baranowski W, Jakowicki JA (1997) ras p21 immunohistochemical detection in human endometrial carcinomas. Gynecol Obstet Invest 44: 132-135
28. Semczuk A, Berbec H, Kostuch M, Cybulski M, Wojcierowski J, Baranowski W (1998) K-ras gene point mutations in human endometrial carcinomas: Correlation with clinicopathological features and patients outcome. J Cancer Res Clin Oncol 124: 695-700
29. Shimizu E, Coxon A, Otterson GA, Steinberg SM, Kratzke RA, Kim YW, Fedorko J, Oie H, Johnson BE, Mulshine JL, Minna JD, Gazdar AF, Kaye FJ (1994) RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 9: 2441-2448
30. Skomedal H, Kristensen GB, Nesland JM, Borresen-Dale A-L, Trope C, Holm R (1999) TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, cdk4, RB, and EGFR in cancers of the uterine corpus. J Pathol 187: 556-562
31. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T (1994) Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048
32. Waldmann V, Rabes HM (1996) What's new in ras genes?. Physiological role of ras genes in signal transduction and significance of ras gene activation in tumorigenesis. Path Res Pract 192: 883-891
33. Weinberg RA (1991) Tumor suppressor genes. Science 254: 1138-1146
34. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330
35. Xing EP, Yang G-Y, Wang L-D, Shi ST, Yang CS (1999) Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 5: 1231-1240
36. Yaginuma Y, Katayama H, Kawai K, Duenas JC, Ishikawa M (1996) Analysis of the retinoblastoma gene in human endometrial carcinoma. Obstet Gynecol 87: 755-759
37. Zhang X, Xu H-J, Murakami Y, Sachse R, Yashima K, Hirohashi S, Hu S-X, Benedict WF, Sekiya T (1994) Deletions of chromosome 13q mutations in retinoblastoma 1 and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res 54: 4177-4182